Associations of the ratios of n-3 to n-6 dietary fatty acids with longitudinal changes in depressive symptoms among us women

American Journal of Epidemiology

Volumn 181, Issue 9, 2015, Pages 691-705

  Beydoun, May A ^a   Fanelli Kuczmarski, Marie T ^a   Beydoun, Hind A ^a   Rostant, Ola S ^a   Evans, Michele K ^a   Zonderman, Alan B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

adults; depressive symptoms; diet; longitudinal studies; n 3 fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; UNSATURATED FATTY ACID;

ADULT; CARBON; EPIDEMIOLOGY; FATTY ACID; FOOD INTAKE; NUMERICAL MODEL; WOMENS HEALTH;

ADULT; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; AGED; DEPRESSIVE DISORDER; MIDDLE AGED; SEXUAL DEVELOPMENT; UNITED STATES;

UNITED STATES;

ADULT; AGED; BALTIMORE; DEPRESSION; DEPRESSIVE DISORDER; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 84928901829     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu334     Document Type: Article

References (86)

1. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998;55(8):694-700.
2. Keller MB, Klerman GL, Lavori PW, et al. Long-term outcome of episodes of major depression. Clinical and public health significance. JAMA. 1984;252(6):788-792.
3. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992;49(10):809-816.
4. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
5. Simopoulos AP. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol. 2011;44(2): 203-215.
6. Grosso G, Galvano F, Marventano S, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev. 2014;2014:313570.
7. Vannice G, Rasmussen H. Position of the academy of nutrition and dietetics: dietary fatty acids for healthy adults. J Acad Nutr Diet. 2014;114(1):136-153.
8. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2002;67(5):311-318.
9. Mamalakis G, Kalogeropoulos N, Andrikopoulos N, et al. Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr. 2006;60(7):882-888.
10. Conklin SM, Manuck SB, Yao JK, et al. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med. 2007;69(9): 932-934.
11. Murakami K, Miyake Y, Sasaki S, et al. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. Pediatrics. 2010;126(3): e623-e630.
12. Panagiotakos DB, Mamplekou E, Pitsavos C, et al. Fatty acids intake and depressive symptomatology in a Greek sample: an epidemiological analysis. J Am Coll Nutr. 2010;29(6): 586-594.
13. Suominen-Taipale AL, Partonen T, Turunen AW, et al. Fish consumption and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis. PLoS One. 2010;5(5):e10530.
14. Hoffmire CA, Block RC, Thevenet-Morrison K, et al. Associations between omega-3 poly-unsaturated fatty acids from fish consumption and severity of depressive symptoms: an analysis of the 2005-2008 National Health and Nutrition Examination Survey. Prostaglandins Leukot Essent Fatty Acids. 2012;86(4-5):155-160.
15. Beydoun MA, Fanelli Kuczmarski MT, Beydoun HA, et al. ε-3 fatty acid intakes are inversely related to elevated depressive symptoms among United States women. J Nutr. 2013;143(11): 1743-1752.
16. Golding J, Steer C, Emmett P, et al. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology. 2009;20(4):598-603.
17. Makrides M, Crowther CA, Gibson RA, et al. Docosahexaenoic acid and post-partum depression-is there a link? Asia Pac J Clin Nutr. 2003;12(Suppl):S37.
18. Astorg P, Couthouis A, Bertrais S, et al. Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-Aged French men and women. Prostaglandins Leukot Essent Fatty Acids. 2008; 78(3):171-182.
19. Lucas M, Mirzaei F, OReilly EJ, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr. 2011;93(6): 1337-1343.
20. Kesse-Guyot E, Touvier M, Andreeva VA, et al. Cross-sectional but not longitudinal association between n-3 fatty acid intake and depressive symptoms: results from the SU. VI.MAX 2. Am J Epidemiol. 2012;175(10):979-987.
21. Colangelo LA, He K, Whooley MA, et al. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition. 2009;25(10):1011-1019.
22. Sanchez-Villegas A, Henríquez P, Figueiras A, et al. Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr. 2007;46(6): 337-346.
23. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159(3):477-479.
24. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebocontrolled trial. Eur Neuropsychopharmacol. 2003;13(4): 267-271.
25. Osher Y, Bersudsky Y, Belmaker RH. Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry. 2005;66(6):726-729.
26. Lespérance F, Frasure-Smith N, St-André E, et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry. 2011;72(8): 1054-1062.
27. Rizzo AM, Corsetto PA, Montorfano G, et al. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters. Nutr J. 2012;11:82.
28. Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, et al. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2013; 23(7):636-644.
29. Astorg P, Bertrais S, Alessandri JM, et al. Long-chain n-3 fatty acid levels in baseline serum phospholipids do not predict later occurrence of depressive episodes: a nested case-control study within a cohort of middle-Aged French men and women. Prostaglandins Leukot Essent Fatty Acids. 2009;81(4): 265-271.
30. Edwards R, Peet M, Shay J, et al. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998;48(2-3):149-155.
31. Schiepers OJ, de Groot RH, Jolles J, et al. Plasma phospholipid fatty acid status and depressive symptoms: association only present in the clinical range. J Affect Disord. 2009;118(1-3): 209-214.
32. Park Y, Kim M, Baek D, et al. Erythrocyte n-3 polyunsaturated fatty acid and seafood intake decrease the risk of depression: case-control study in Korea. Ann Nutr Metab. 2012;61(1): 25-31.
33. Appleton KM, Peters TJ, Hayward RC, et al. Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association? Soc Psychiatry Psychiatr Epidemiol. 2007;42(2):100-104.
34. Mamalakis G, Kiriakakis M, Tsibinos G, et al. Lack of an association of depression with n-3 polyunsaturated fatty acids in adipose tissue and serum phospholipids in healthy adults. Pharmacol Biochem Behav. 2008;89(1):6-10.
35. Murakami K, Mizoue T, Sasaki S, et al. Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition. 2008;24(2):140-147.
36. Tsuboi H, Watanabe M, Kobayashi F, et al. Associations of depressive symptoms with serum proportions of palmitic and arachidonic acids, and ?-tocopherol effects among male population-A preliminary study. Clin Nutr. 2013;32(2): 289-293.
37. Persons JE, Robinson JG, Ammann EM, et al. Omega-3 fatty acid biomarkers and subsequent depressive symptoms. Int J Geriatr Psychiatry. 2014;29(7):747-757.
38. Crowe FL, Skeaff CM, Green TJ, et al. Serum phospholipid n 3 long-chain polyunsaturated fatty acids and physical and mental health in a population-based survey of New Zealand adolescents and adults. Am J Clin Nutr. 2007;86(5): 1278-1285.
39. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160(5):996-998.
40. Rogers PJ, Appleton KM, Kessler D, et al. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr. 2008; 99(2):421-431.
41. Zhang J, Li Y. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial- comments by Zhang and Li. Br J Nutr. 2008;100(6): 1347-1348.
42. Antypa N, Van der Does AJ, Smelt AH, et al. Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol. 2009;23(7):831-840.
43. Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-Analysis. Mol Psychiatry. 2012;17(12):1272-1282.
44. Lin PY, Su KP. A meta-Analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056-1061.
45. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-Analysis of randomized controlled trials. J Am Coll Nutr. 2009;28(5): 525-542.
46. Wolfe AR, Ogbonna EM, Lim S, et al. Dietary linoleic and oleic fatty acids in relation to severe depressed mood: 10 years follow-up of a national cohort. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(6):972-977.
47. Féart C, Peuchant E, Letenneur L, et al. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr. 2008;87(5):1156-1162.
48. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1(3):385-401.
49. Ramos MI, Allen LH, Haan MN, et al. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr. 2004;80(4):1024-1028.
50. Myers JK, Weissman MM. Use of a self-report symptom scale to detect depression in a community sample. Am J Psychiatry. 1980;137(9):1081-1084.
51. Nguyen HT, Kitner-Triolo M, Evans MK, et al. Factorial invariance of the CES-D in low socioeconomic status African Americans compared with a nationally representative sample. Psychiatry Res. 2004;126(2):177-187.
52. Conway JM, Ingwersen LA, Moshfegh AJ. Accuracy of dietary recall using the USDA five-step multiple-pass method in men: an observational validation study. J Am Diet Assoc. 2004; 104(4):595-603.
53. Conway JM, Ingwersen LA, Vinyard BT, et al. Effectiveness of the US Department of Agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women. Am J Clin Nutr. 2003;77(5):1171-1178.
54. Moshfegh AJ, Rhodes DG, Baer DJ, et al. The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr. 2008;88(2): 324-332.
55. Blanton CA, Moshfegh AJ, Baer DJ, et al. The USDA Automated Multiple-Pass Method accurately estimates group total energy and nutrient intake. J Nutr. 2006;136(10): 2594-2599.
56. RumplerWV, Kramer M, Rhodes DG, et al. Identifying sources of reporting error using measured food intake. Eur J Clin Nutr. 2008;62(4):544-552.
57. United States Department of Agriculture (USDA), Agriculture Research Service FSRG. Food and Nutrient Database for Dietary Studies, 3.0. Beltsville, MD: United States Department of Agriculture; 2008. http://www.ars.usda.gov/News/docs. htm?docid=12089. Accessed October 2014.
58. Lands WE, Libelt B, Morris A, et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta. 1992;1180(2): 147-162.
59. Lands WE, Morris A, Libelt B. Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids. 1990;25(9):505-516.
60. Morris DW, Trivedi MH, Rush AJ. Folate and unipolar depression. J Altern Complement Med. 2008;14(3): 277-285.
61. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1996;54(12):382-390.
62. Kivelä SL, Pahkala K, Eronen A. Depression in the aged: relation to folate and vitamins C and B12. Biol Psychiatry. 1989;26(2):210-213.
63. Oishi J, Doi H, Kawakami N. Nutrition and depressive symptoms in community-dwelling elderly persons in Japan. Acta Med Okayama. 2009;63(1):9-17.
64. Owen AJ, Batterham MJ, Probst YC, et al. Low plasma vitamin E levels in major depression: diet or disease? Eur J Clin Nutr. 2005;59(2):304-306.
65. Maes M, De Vos N, Pioli R, et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord. 2000;58(3): 241-246.
66. Willet WC. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998.
67. Stata Corporation. Statistics/data analysis, release 13.0. College Station, TX: Stata Corporation; 2013.
68. Blackwell E, de Leon CF, Miller GE. Applying mixed regression models to the analysis of repeated-measures data in psychosomatic medicine. Psychosom Med. 2006;68(6):870-878.
69. Heckman JJ. Sample selection bias as a specification error. Econometrica. 1979;47(1):153-161.
70. Beydoun MA, Boueiz A, Abougergi MS, et al. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. Neurobiol Aging. 2012;33(4):720-731.e4.
71. Selvin S. Statistical Analysis of Epidemiologic Data. 3rd ed. Oxford, UK: Oxford University Press; 2004.
72. Hochberg Y, Tamhane AC. Multiple Comparison Procedures. New York, NY: John Wiley &Sons, Inc.; 1987.
73. Haag M. Essential fatty acids and the brain. Can J Psychiatry. 2003;48(3):195-203.
74. Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci. 2000; 18(4-5):383-399.
75. Czysz AH, Rasenick MM. G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids. CNS Neurol Disord Drug Targets. 2013;12(4):466-473.
76. Murphy MG. Membrane fatty acids, lipid peroxidation and adenylate cyclase activity in cultured neural cells. Biochem Biophys Res Commun. 1985;132(2):757-763.
77. Nicolas C, Lacasa D, Giudicelli Y, et al. Dietary (n-6) polyunsaturated fatty acids affect beta-Adrenergic receptor binding and adenylate cyclase activity in pig adipocyte plasma membrane. J Nutr. 1991;121(8):1179-1186.
78. Speizer LA, Watson MJ, Brunton LL. Differential effects of omega-3 fish oils on protein kinase activities in vitro. Am J Physiol. 1991;261(1 pt 1):E109-E114.
79. Irvine RF, Letcher AJ, Dawson RM. Fatty acid stimulation of membrane phosphatidylinositol hydrolysis by brain phosphatidylinositol phosphodiesterase. Biochem J. 1979; 178(2):497-500.
80. McPhail LC, Clayton CC, Snyderman R. A potential second messenger role for unsaturated fatty acids: activation of Ca2+- dependent protein kinase. Science. 1984;224(4649):622-625.
81. Horrobin DF, Bennett CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids. 1999;60(4):217-234.
82. Kearns SD, Haag M. The effect of omega-3 fatty acids on Ca-ATPase in rat cerebral cortex. Prostaglandins Leukot Essent Fatty Acids. 2002;67(5):303-308.
83. Harbeby E, Pifferi F, Jouin M, et al. N-3 fatty acids, neuronal activity and energy metabolism in the brain. OCL. 2012;19(4): 238-244.
84. Giltay EJ, Gooren LJ, Toorians AW, et al. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr. 2004;80(5):1167-1174.
85. Bakewell L, Burdge GC, Calder PC. Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr. 2006;96(1):93-99.
86. Decsi T, Kennedy K. Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr. 2011;94(6 suppl): 1914S-1919S.